Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracranial hemorrhage after reperfusion therapy in acute ischemic stroke
TCTR20261030002Completed
- Sponsor
- Lampang Hospital
- Start
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of tissue-plasminogen activator in ischemic stroke (3 arms), sponsored by Lampang Hospital. Primary endpoint: Any intracranial hemorrhage. Started Aug 2020; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on TCTR20261030002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261030002.